AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

By: AbCellera Biologics Inc. via Business Wire

October 07, 2025 at 16:05 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:

Truist Securities BioPharma Symposium, November 6, 2025
Stifel Healthcare Conference, November 11-13, 2025
Jefferies Global Healthcare Conference, November 18-20, 2025
Piper Sandler 37th Annual Healthcare Conference, December 2-4, 2025

Visit AbCellera's Investor Relations website for additional information.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251007123988/en/

Contacts

Inquiries

Media: Tiffany Chiu; media@abcellera.com, +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.; partnering@abcellera.com, +1(604)559-9005

Investor Relations: Peter Ahn; ir@abcellera.com, +1(778)729-9116

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Symbol	Price	Change (%)
AMZN	247.03	-2.96 (-1.18%)
AAPL	326.42	-0.17 (-0.05%)
AMD	527.58	+24.01 (4.77%)
BAC	60.92	+0.50 (0.84%)
GOOG	347.60	-3.77 (-1.07%)
META	645.89	+0.04 (0.01%)
MSFT	398.28	-4.01 (-1.00%)
NVDA	205.72	+2.44 (1.20%)
ORCL	124.67	+3.29 (2.71%)
TSLA	382.06	+12.50 (3.38%)

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Contacts

More News

Recent Quotes